Yun, SergiComín Colet, J.Calero Molina, EstherHidalgo, EncarnaciónJosé Bazán, NúriaCobo Marcos, MartaSoria, TeresaLlácer, PauFernández, CristinaGarcía Pinilla, José ManuelCruzado, ConcepciónJuan Bagudá, Javier deEt.al.2025-10-142025-10-142025Yun, S., Comín-Colet, J., Calero-Molina, E., Hidalgo, E., José-Bazán, N., Cobo Marcos, M., Soria, T., Llàcer, P., Fernández, C., García-Pinilla, J. M., Cruzado, C., González-Franco, Á., García-Marina, E. M., Morales-Rull, J. L., Solé, C., García-Romero, E., Núñez, J., Civera, J., Fernández, C., … Fernández, J. (2025). Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (Hermes): A multicentre, randomised controlled trial. The Lancet Digital Health, 7(5), 100866. https://doi.org/10.1016/j.landig.2025.02.0062589-7500https://hdl.handle.net/11268/16390he potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk of cardiovascular events in patients with heart failure during the early post-discharge period (ie, the vulnerable phase) has not been evaluated to our knowledge. We investigated the efficacy of incorporating mHealth into routine heart failure management in vulnerable-phase patients.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/TelemedicinaInfarto del MiocardioEnsayo Clínico Controlado AleatorioEvaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trialjournal article10.1016/j.landig.2025.02.006open accessSistema cardiovascularInvestigación médicaGoal 3: Ensure healthy lives and promote well-being for all at all ages